CancerEthicsDoc's profile picture. #Oncology #Ethics #Trials Med Onc/PhD candidate @SydHealthEthics Aim: conversations which promote human flourishing.Views my own. Retweets do not = endorsement.

Dr Sarah Heynemann

@CancerEthicsDoc

#Oncology #Ethics #Trials Med Onc/PhD candidate @SydHealthEthics Aim: conversations which promote human flourishing.Views my own. Retweets do not = endorsement.

Pinned

⭐️ NEW PUBLICATION⭐️In 2024 @iaslc's JTO published a debate on the role of #equipoise in Ph3 RCTs of precision oncology therapeutics in #NSCLC. (See prior 🧵x.com/CancerEthicsDo…) In a new letter we highlight key implications if equipoise is uncertain in a given RCT...

⭐️ New Paper⭐️ Equipoise + modern cancer RCTs, using thoracic oncology as an exemplar - whose uncertainty matters (most)? 💥 A debate💥 jto.org/article/S1556-… with @WendyLipworth McLachlan @JenAMPhilip @TommyJohn00 Kerridge @SydHealthEthics In this paper, we outline- a 🧵



Dr Sarah Heynemann reposted

How do oncologists balance maintaining hope & truth-telling? When & how should they challenge unrealistic hope? Less than 1 wk to go for this MOGA Medical Ethics Webinar. Participants can log CPD points for ethics & professional behaviour. Register today! moga.org.au/medical-ethics…


Dr Sarah Heynemann reposted

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival: “For every 16 people, exercise prevents 1 person from recurrent/new cancer” “For every 14 people, exercise prevents 1 person from dying”

DrNicolasHart's tweet image. A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival:

“For every 16 people, exercise prevents 1 person from recurrent/new cancer”

“For every 14 people, exercise prevents 1 person from dying”
DrNicolasHart's tweet image. A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival:

“For every 16 people, exercise prevents 1 person from recurrent/new cancer”

“For every 14 people, exercise prevents 1 person from dying”
DrNicolasHart's tweet image. A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival:

“For every 16 people, exercise prevents 1 person from recurrent/new cancer”

“For every 14 people, exercise prevents 1 person from dying”
DrNicolasHart's tweet image. A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival:

“For every 16 people, exercise prevents 1 person from recurrent/new cancer”

“For every 14 people, exercise prevents 1 person from dying”

Dr Sarah Heynemann reposted

📰IN THE MEDIA⬇️| A new best practice guide developed by @PathologyRCPA and @TOGAANZ offers valuable recommendations for lung cancer care. However, concerns remain about the potential impact of stigma on participation in the #NationalLungCancerScreeningProgram. 🔬A media content…


Dr Sarah Heynemann reposted

Do you work on clinical trials? We need your help to understand the challenges to designing & delivering greener trials. Only 30 responses so far but we can all have a say on this topic. Please take 10 minutes to tell us what you think tinyurl.com/GreenTrials RTs welcome

forms.office.com

Microsoft Forms

Microsoft Forms


Dr Sarah Heynemann reposted

With ADCs bringing cytotoxic payloads, good to get a reminder in these basics, to understand toxicities

Cancer Chemotherapy @Cancer_Cell

dr_yakupergun's tweet image. Cancer Chemotherapy

@Cancer_Cell


Dr Sarah Heynemann reposted

It’s the run up to the holidays so time to resurrect #MethodologyMonday #19. Published c1906 in Nature by the statistician Francis Galton, here is the scientific way to cut your Christmas cake 🎂🎄🔪😊 Enjoy! galton.org/essays/1900-19…

MarionKCampbell's tweet image. It’s the run up to the holidays so time to resurrect #MethodologyMonday #19. Published c1906 in Nature by the statistician Francis Galton, here is the scientific way to cut your Christmas cake 🎂🎄🔪😊 Enjoy!
galton.org/essays/1900-19…

Dr Sarah Heynemann reposted

Our latest in @ActaOncol led by @JuliaLaiKwon on survivorship care for advanced or metastatic cancer. ⏳ Regular discussions about prognosis ✅ Assessment of unmet needs 📝 Referral to services (PROMs) 🆕 New models of care: Surv and Pall ☎️ Communication and care coordination.

DrNicolasHart's tweet image. Our latest in @ActaOncol led by @JuliaLaiKwon on survivorship care for advanced or metastatic cancer.

⏳ Regular discussions about prognosis
✅ Assessment of unmet needs
📝 Referral to services (PROMs)
🆕 New models of care: Surv and Pall
☎️ Communication and care coordination.

Realities of the modern EBM/perception of “evidence”/access to drugs conversation #AABHL24 @AABHL @SydHealthEthics

CancerEthicsDoc's tweet image. Realities of the modern EBM/perception of “evidence”/access to drugs conversation #AABHL24 @AABHL @SydHealthEthics

Some thoughts to ponder as #AABHL24 kicks off by @IABioethics president Caesar Atuire re the challenges for bioethics to ponder in the modern era @AABHL @SydHealthEthics

CancerEthicsDoc's tweet image. Some thoughts to ponder as #AABHL24 kicks off by @IABioethics president Caesar Atuire re the challenges for bioethics to ponder in the modern era @AABHL @SydHealthEthics

Dr Sarah Heynemann reposted

Avène is supporting Melanoma and Skin Cancer Trials by donating $1 from every Avène Sunsitive Sunscreen ® sold in-store at Chemist Warehouse between 1 November and 31 December 2024. masc.org.au/avene/ #avene #sunsitive #sunscreen #sunsafety #SPF50+

MASC_Trials's tweet image. Avène is supporting Melanoma and Skin Cancer Trials by donating $1 from every Avène Sunsitive Sunscreen ® sold in-store at Chemist Warehouse between 1 November and 31 December 2024.

masc.org.au/avene/

 #avene #sunsitive #sunscreen #sunsafety #SPF50+

Dr Sarah Heynemann reposted

Abhijit Pal has so much to say on equity in cancer care that it’s hard for mere mortals to keep up with him. However let’s start at the beginning…why does it matter? Here’s why! #COSA2024

thelimbiconc's tweet image. Abhijit Pal has so much to say on equity in cancer care that it’s hard for mere mortals to keep up with him. However let’s start at the beginning…why does it matter? Here’s why! #COSA2024

Loading...

Something went wrong.


Something went wrong.